[1]Patent:WO2016/22521,2016,A1.Locationinpatent:Paragraph00132
[2]JournalofMedicinalChemistry,2016,vol.59,p.3264-3271
648904-84-1
959961-65-0
1541305-10-5
1370025-62-9
1207970-78-2
915201-07-9 | 3-Chloro-5-methoxyphenylboronic acid | AA00GS3X | MFCD03095046
914636-87-6 | 4-[6-(trifluoromethyl)pyridin-2-yl]morpholine | AA00GSDH | MFCD08056342
917572-28-2 | (S)-4-Benzyl-3-chloromethyl-morpholine | AA00GSM0 | MFCD10687133
920-34-3 | 2-BROMOACRYLONITRILE | AA00GST1 | MFCD00040191
917561-99-0 | 4-Amino-2,8-bis(trifluoromethyl)-quinoline | AA00GT32 | MFCD08669716
913835-55-9 | 4-(N-Ethyl-N-(4-methoxybenzyl)sulfamoyl)phenylboronic acid | AA00GTA9 | MFCD08689489
887409-11-2 | 4-Cyclopropyl-2-(trifluoromethyl)pyrimidine-5-carboxylic acid ethyl ester | AA00GTF3 | MFCD07367384
915919-68-5 | 5-Cyclohexylthiophene-2-carbaldehyde | AA00GTLK | MFCD08059743
915924-07-1 | 2-Amino-6-isobutyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-ol | AA00GTP6 | MFCD08691913
906673-24-3 | 4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile | AA00GTY2 | MFCD17169940